Live data from Hacker News

An idiot’s guide to lead optimisation for proteins

magnusross.github.io

11–18 of 18 posts

Re: An idiot’s guide to lead optimisation for proteins

#12
post #8

how many therapeutic proteins are there that aren't mabs or ~naturally occurring proteins (insulin, modified insulins, hirudin, cerezyme etc)? I can think of: etanercept

A large and rapidly growing number.

The largest commercial classes of multi-domain therapeutic proteins include the crispr (and similar) that drive gene therapies, and the chimeric antigen receptors (and similar) that drive cell therapies.

But lead optimization there look different than this page’s efforts.

Re: An idiot’s guide to lead optimisation for proteins

#14
post #12
post #8

how many therapeutic proteins are there that aren't mabs or ~naturally occurring proteins (insulin, modified insulins, hirudin, cerezyme etc)? I can think of: etanercept

A large and rapidly growing number. The largest commercial classes of multi-domain therapeutic proteins include the crispr (and similar) that drive gene therapies, and the chimeric antigen receptors (and similar) that drive cell therapies. But lead optimization there look different than this page’s efforts.

Oh yeah good point on crispr and the antibody chimeras (which etanercept is)

I guess I imagine one of the highest order obstacle to protein therapeutics to be immunogenicity, which is really hard to design around for a de Novo protein

Re: An idiot’s guide to lead optimisation for proteins

#17
post #13

Anyone else read this as "An idiot's guide to Pb optimization for proteins," as in avoiding contaminated dietary protein isolates?

The article at least explains what it means in literally the first sentence, which is a lot better than half the things posted on HN!
Post reply on HN